France has reported the first documented human infection with Shamonda virus, an animal-associated pathogen previously not known to infect humans. The patient, who had a severely weakened immune system and was receiving treatment for a serious illness in Lyon, died in early October, French authorities said on October 22.
The World Health Organization (WHO) is working with French officials to establish how the infection occurred, whether the virus contributed to the patient’s death and what the discovery means for public health.
The case is exceptional because Shamonda virus had circulated among animals for decades without a documented human infection. French authorities believe the patient may have contracted it through the bite of an infected Culicoides midge, a small insect that transmits the virus among animals. The investigation is continuing, and the precise route of infection has not been conclusively established.
Despite the death, French authorities said no health risk to the general population had been identified based on current knowledge. The European Centre for Disease Prevention and Control (ECDC) is also monitoring the case and working with national authorities to assess its implications.
What Is Shamonda Virus and How Does It Spread?
Shamonda virus belongs to the Orthobunyavirus genus, a group of viruses that includes pathogens affecting both animals and humans. It was first identified in Nigeria in the mid-1960s and has since been reported sporadically among cattle in parts of Africa and Japan.
The virus primarily affects livestock, particularly cattle. Sheep, goats and horses can also be infected. In animals, infections may be associated with fever, diarrhoea, lethargy and reduced milk production. Reproductive complications have also been reported or are being investigated in affected livestock.
Transmission is believed to occur mainly through bites from infected Culicoides midges. These small, biting insects act as vectors, carrying the virus between susceptible animals. The same general type of insect transmits other livestock-associated viruses.
Shamonda virus was detected in European livestock for the first time in 2026, including on cattle farms in France. Its emergence prompted investigations into its spread and effects on animal health.
Before the French human case, there had been no documented evidence that Shamonda virus could infect people. Researchers had considered it an animal-associated virus without established human transmission.
The discovery changes what scientists know about the virus, but it does not establish that human infections are common or that the pathogen can spread readily among people. One documented case is insufficient to determine how frequently such infections might occur or which factors make a person susceptible.
Why Did the Patient Die, and Is There a Risk to Humans?
The patient’s severely compromised immune system is an important part of the investigation. People with weakened immune systems can be more vulnerable to certain infections and may face a higher risk of severe complications. However, the available evidence does not establish that immunosuppression alone explains why this patient became infected.
French authorities said the patient had been treated for a serious underlying illness at the Hospices Civils de Lyon. Investigations into the clinical course, laboratory findings and circumstances of exposure are ongoing. The ECDC has said officials are examining whether Shamonda virus caused or contributed to the death.
The suspected route of infection is a bite from an infected midge in eastern France, where the virus was circulating among animals during the spring and summer of 2026. Establishing that route will be important for understanding whether the infection resulted from an unusual exposure or whether other transmission pathways need to be considered.
WHO Director-General Tedros Adhanom Ghebreyesus said the agency was in contact with French authorities to gather information about the source of the infection, possible transmission routes and potential public health implications. “The French patient was in an area where the Shamonda virus was circulating in animals and where Culicoides midges were also present,” the WHO Director-General said.
The investigation needs to answer several questions: whether the virus can infect humans under particular circumstances, whether the patient’s underlying illness or immune status increased susceptibility, and whether any additional human infections have gone undetected.
For now, there is no evidence from this single case to suggest sustained human-to-human transmission. French authorities have said no risk to the general population has been identified based on current knowledge. That assessment could be updated as investigators obtain more evidence.
The immediate priority is to determine how the infection occurred and whether the virus poses a broader threat beyond its established presence in livestock. The case also highlights the importance of monitoring diseases at the intersection of human, animal and environmental health, particularly when a pathogen appears in a new region or is detected in a previously unrecognised host.
Shelton Rozario